Netanyahu : ICC war crimes decision is hypocrisy and anti-Semitism ynetnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ynetnews.com Daily Mail and Mail on Sunday newspapers.
Israeli-founded cybersecurity company SentinelOne is preparing for an initial public offering at a value of around $10 billion. According to a report by Bloomberg, the offering could happen this year, although the company’s plans are in the early stages and the valuation and timing could still change. SentinelOne didn t respond to the report.
Should the IPO go ahead as reported, it would be the largest ever by an Israeli-founded cybersecurity company, with SentinelOne having been founded in 2013 by Tomer Weingarten and Almog Cohen. Many Israeli companies have accelerated their preparations for going public over recent months, whether via an IPO or a SPAC, hoping to take advantage of the surging market which is gifting tech companies massive valuations.
The results of Israel s vaccination drive is continuing to inspire hope around the world. The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed, based on data collected on the Israeli rollout, shows the shot is highly effective at preventing Covid-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies.
Up until now, most data on the efficacy of Covid-19 vaccines has come under controlled conditions in clinical trials, leaving an element of uncertainty over how results would translate into the real world with its unpredictable variables.
Ran Balicer, Director of Health Policy Planning at Clalit. Photo: Orel Cohen The research in Israel - two months into one of the world s fastest rollouts, providing a rich source of data - showed two doses of the Pfizer shot cut symptomatic Covid-19 cases by 94% across all age groups, and severe illnesses by nearly as much.
Intel’s incoming CEO Patrick Gelsinger is set to take the helm on Monday. Although he was only officially appointed a month ago, this isn’t the first time he has been offered the position. Since 2013, his name has come up as a leading candidate, but Gelsinger had refused and preferred to stay on as CEO of VMware, where he managed to double the company’s size. Now, he’s getting a whole different Intel than in 2013, one that may not be as focused.
The chip making giant’s hazy future is the result of a decade of poor or undecisive business decisions. There is hardly a sector that the chip giant hasn’t tried entering: computer processors, smartphone processors, computer manufacturing (such as the NUC line of mini PCs), wearables, drones, autonomous cars (Mobileye), navigation (Moovit), sporting event photography, cloud computing, network cards, modems, graphics cards, drivers and software, memory chips, cybersecurity, artificial intelligence, big data, virtual reality, a
Pfizer vaccine reduces rate of symptomatic infections by 94%, research shows
Study also shows that a week after receiving the second dose, the vaccine is 91-99% efficient in preventing the pathogen from evolving into a serious illness; results expected to become much more accurate as time passes and as more Israelis pass the-two week benchmark after second jab
Adir Yanko, Yaron Druckman |
Published: 02.14.21 , 22:10
Research conducted by the Clalit Health Fund released Sunday shows that Pfizer’s coronavirus vaccine is exceptionally effective in preventing infection and severe illness in all age groups, including those aged 70 and over.
The study includes data on some 1.2 million Israelis insured by Clalit, of whom about 600,000 have received both doses of the Pfizer’s vaccine.